ARCHIVES

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 30, 2003

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

Gardasil Approved To Prevent Vulvar And Vaginal Cancers

September 26, 2008

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012